Podcasts about pharmd

Effective management of adverse events and addressing barriers to care are critical to optimizing outcomes and maintaining quality of life for patients receiving CDK4/6 inhibitors. In this episode, CANCER BUZZ speaks with Julia Lea Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator in solid tumor oncology at Atrium Health Levine Cancer Institute about proactive, team-based strategies to identify, monitor, and manage treatment-related toxicities in patients with early-stage and metastatic HR-positive, HER2-negative breast cancer. Dr. Ziegengeist sheds light on the patient journey, the roles of various multidisciplinary care team members, and useful resources for language and literacy barriers. “I think the biggest thing that is specific to CDK4/6 inhibitors is... eligibility criteria and when we're using the drugs in what setting, having those monitoring protocols and getting that multidisciplinary collaboration is really key.” – Julia Lea Ziegengeist, PharmD, BCOP   Julia Lea Ziegengeist, PharmD, BCOP   Clinical Pharmacist Coordinator, Solid Tumor Oncology   Levine Cancer Institute   Atrium Health   Charlotte, NC       Resources: ACCC Resource: CDK4/6 Inhibitors Management  ACCC CDK4/6 Inhibitors Infographic 

Enterocutaneous fistulas present one of the most complex challenges in clinical nutrition—and parenteral nutrition often plays a central role in management. In our latest episode, we're joined by Vanessa Kumpf, PharmD, leading expert in nutrition support, to discuss evidence-based strategies, real-world decision-making, and how to optimize outcomes for these high-risk patients.

Follow Jason on Tik Tok @CarnivRX   If you liked this and want to learn more go to my new website www.DrAnthonyChaffee.com

Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Asking for and getting a raise can make a significant difference in your financial plan for years to come. In this episode, Tim Ulbrich walks through a five-step playbook with practical tips and strategies to help you confidently ask for and get the raise you deserve. Episode Summary Asking for and getting a raise can make a massive difference in your financial plan, not just today, but for years and even decades to come. For many pharmacists, the thought of walking into their boss's office and asking for more money can feel as unpleasant as getting a cavity filled. It's uncomfortable, awkward, and full of “what ifs”: What if they say no? What if I ruin the relationship? What if they think I'm being greedy? The truth is, most people never get a big raise for one simple reason: they never ask. And that “ask” isn't just about adding dollars to your paycheck. It's about building confidence and advocating for the value you bring to your role. In this episode, YFP Co-Founder & CEO, Tim Ulbrich, PharmD, breaks down a five-step playbook with practical examples, real-world negotiation tips, and a few favorite strategies from Chris Voss's Never Split the Difference. Whether you're aiming for your first raise or looking to boost your income long term, this episode gives you the tools to confidently ask for and actually get the raise you deserve. Mentioned on the Show YFP YouTube Channel YFP 384: Beyond Salary: Negotiating Your Value in the Workplace Never Split the Difference by Chris Voss Your Financial Pharmacist  

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginHow do you tackle one of healthcare's biggest challenges from behind the pharmacy counter?That's the question at the heart

Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss how pharmacy turnover rates impact independents, chains, and the patients they serve.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Evandro Bezerra, MD As CAR T-cell therapy advances, so does the complexity of adverse event monitoring. Due to evolving insights into acute toxicities, infections, cytopenias, and secondary malignancies, both inpatient and outpatient care models are adapting to meet new standards. Joining Dr. Charles Turck to discuss practical strategies and emerging tools for managing post-CAR T toxicities across the continuum of care is Dr. Evandro Bezerra, Clinical Assistant Professor at Ohio State University Comprehensive Cancer Center in Columbus.

On this episode, we define obsessive-compulsive disorder (OCD) and describe its clinical presentations, diagnostic criteria, and underlying pathophysiology. We evaluate current guidelines and evidence-based treatment strategies for managing OCD, including pharmacologic and non-pharmacologic interventions. We also, compare and contrast the efficacy, safety profiles, and appropriate use of selective serotonin reuptake inhibitors (SSRIs), cognitive behavioral therapy (CBT), and other emerging treatment modalities for OCD.  Dr. David Osser's psychopharmacology Algorithm Website  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

On episode 525 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews author and lactation pharmacologist Dr. Kaytlin Krutsch, PhD, PharmD, MBA, BCPS. In the course of their conversation, Keith and Dr. Krutsch discuss the history and science behind the very specialized topic of lactation pharmacology, and why it should be of great importance to all healthcare professionals. Kaytlin Krutsch, PhD, PharmD, MBA, BCPS is a lactation pharmacologist who literally wrote the book on medications in human milk with Dr. Thomas Hale, Hale's Medications and Mothers' Milk. Dr. Krutsch is both Director of the Infant Risk Center and Associate Professor at the Texas Tech University Health Sciences Center, and advises the Food and Drug Administration, the Human Milk Banking Association of Northern America, and the pharmaceutical industry on lactation pharmacology and lactation research. Dr. Krutsch believes families deserve better answers to questions about breastfeeding and medications, and designs research that addresses their questions while creating a comprehensive information cycle that empowers families. This episode of the Nurse Keith Show is brought to you in collaboration with Springer Publishing, who have been delivering award-winning healthcare education and exam prep materials focused on nursing, behavioral health, and the health sciences for more than 70 years. We thank Springer Publishing for their support. Connect with Dr. Kaytlin Krutsch and The Infant Risk Center ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn Instagram Facebook Infant Risk Center website Hale's Medications and Mother's Milk Contact Nurse Keith about holistic career coaching to elevate your nursing and healthcare career at ⁠⁠⁠⁠⁠⁠⁠NurseKeith.com⁠⁠⁠⁠⁠⁠⁠. Keith also offers services as a motivational and keynote speaker and freelance nurse writer. You can always find Keith on⁠⁠⁠⁠⁠⁠⁠ LinkedIn⁠⁠⁠⁠⁠⁠⁠. Are you looking for a novel way to empower your career and move forward in life? Keith's wife, Shada McKenzie, is a gifted astrologer and reader of the tarot who combines ancient and modern techniques to provide valuable insights into your motivations, aspirations, and life trajectory, and she offers listeners of The Nurse Keith Show a 10% discount on their first consultation. Contact Shada at ⁠⁠⁠⁠⁠⁠⁠TheCircelandtheDot.com ⁠⁠⁠⁠⁠⁠⁠or shada@thecircleandthedot.com.

Celebrate the American Diabetes Association®'s (ADA) 85th anniversary with Drs. Neil Skolnik and Sara Wettergreen, joined by Dr. Marlon Pragnell, Charlene Wallace, and Stacey Krawczyk. Together, they'll reflect on the ADA's legacy of groundbreaking research and how it continues to shape the programs and resources available today. The conversation will also highlight practical tools—from nutrition guidance to the National Diabetes Prevention Program—to support you and your loved ones in managing or preventing diabetes. Because it all matters. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Charlene Wallace, MBA, Vice President of Diabetes Prevention at the ADA Stacey Krawczyk, MS, RD, Director of Nutrition and Wellness at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Research Impact   Learn More About the National Diabetes Prevention Program    Eating for Diabetes Management   Diabetes Food Hub   More on the ADA's 85th Anniversary

The Future Is Now: APhA President Randy McDonough on Leading Change in Independent PharmacyWhat does the future of independent pharmacy look like—and how do we get there?In this powerful episode of Independent Insights, APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Randy shares his frontline perspective as both a national leader and a practicing owner.Whether you're a pharmacist, technician, or pharmacy owner, this episode will leave you inspired, informed, and ready to take action. Tune in and be part of the movement to redefine the role—and the value—of independent pharmacy in healthcare.HostSuzanne Feeney, PharmDSenior Director, Pharmacy SolutionsMcKesson/ Health MartGuestsRandy McDonough, PharmD, MS, BCGP, BCPS, FAPhAPresident, American Pharmacists Association (APhA) and Health Mart Pharmacy OwnerNancy Lyons, BSPharm, MBA, CDCESVice President, Chief Pharmacy OfficerMcKesson/ Health MartResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for: Helpful CE courses, advanced trainings, and more Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

When you think about building wealth in medicine, do you picture yourself working at one job until retirement? My guest today, Kristin Burton, proves there's a better way. She began her career like many of us, buried in student loan debt and working long hours. After paying off $161,000 in just 16 months, she realized financial freedom was about more than debt elimination. Kristin shares how she shifted her focus from paying bills to building assets, investing aggressively in her twenties, and eventually creating income streams outside of medicine. We talk about the mindset shifts healthcare professionals must make to get ahead, and Kristin also shares how she helps other PAs, NPs, and PharmDs rethink their financial journey, create sustainable wealth, and avoid burnout in medicine. If you're wondering whether it's possible to thrive in your career, grow your wealth, and still have time for family and passions, this episode is for you! “If you can create a gap between your expenses and income and then create some assets with the gap, it's almost inevitable that you're gonna end up building some wealth.” ~ Kristin Burton In This Episode:- Kristin Burton's journey of paying $161k in student debt- What steps did she take toward becoming a millionaire?- Why your income level doesn't matter in building wealth- What Kristin would do differently and her current beliefs- Biggest client "head trash": PSLF myths and the 4% 401k mindset - How do you help healthcare professionals avoid lifestyle inflation?- Kristin's book recommendations - Redefining wealth: from net worth goals to "what is enough?" - How to find out more and join Kristin's community Book Recommendations Mentioned in the Episode: The Alchemist by Paulo Coelho: https://a.co/d/3yayzkg 10x Is Easier Than 2x by Dr. Benjamin Hardy & Dan Sullivan: https://a.co/d/hlbLEbG Who Not How by Dr. Benjamin Hardy & Dan Sullivan: https://a.co/d/2Ol8RjwThe 5 Types of Wealth by Sahil Bloom: https://a.co/d/6SMYeNH Die With Zero by Bill Perkins: https://a.co/d/6ae8TSq Join The Millionaires in Medicine Club!Learn how to clear debt and build wealth as a PA, NP, or PharmD: https://www.millionairesinmedicine.com/community Connect with Kristin Burton: Website: https://www.millionairesinmedicine.com/ LinkedIn: https://www.linkedin.com/in/kristin-burton-pac `Resources:➡️ Free community of high-performing physicians: the Physician Wealth Accelerator - https://limitless-md.mn.co/➡️ Check out my programs - https://vikramraya.com/coaching/➡️ Apply to become a Limitless MD -

The Joint Commission's updated accreditation manual is designed to simplify requirements, enhance clarity, and better support healthcare organizations in survey preparation. In this episode of VerifiedRx, host Carolyn Liptak is joined by Dr. Robert Campbell of the Joint Commission and Diana Scott of Vizient to unpack the most significant changes. From the shift to National Performance Goals and medication safety priorities to the latest challenges in compounding, labeling, and hazardous drug handling, the conversation highlights practical insights to help pharmacy leaders stay compliant and survey-ready.   Guest speakers: Robert Campbell, PharmD, BCSCP Sr. Director, Standards Interpretation, Accreditation Decision Management,Medication Safety Division of Accreditation and Certification Operations Joint Commission   Diana Scott, MHA, RN, CPHQ Principal, Regulatory and Accreditation Services Vizient   Host:  Carolyn Liptak, , BS Pharm, MBA   Vizient   Show Notes:  [01:16-01:51] Diana and Robert Backgrounds [01:52-02:43] Changes made to the hospital and critical access hospital manuals [02:44-03:09] Changes to the chapters themselves [03:10-04:08] National Performance Goals and elaborate on those that are relevant to medication safety and pharmacy services [04:09-05:15] The top medication management challenges [05:16-06:29] Pain management not being aligned and titration orders [06:30-06:56] Insufficient communication between pharmacists, prescribers and nurses when it comes to medication orders [06:57-08:02] Themes around labeling requirements for stored medications [08:03-08:46] Anything different in removing expired meds from patient care areas and in the pharmacy this area than previous years [08:47-10:58] Issues related to storing meds specifically per the package insert [10:59-11:55] Common issues seen inside the pharmacy regarding sterile compounding, noncompliance include hand hygiene, garbing, PPE, and cleaning and disinfecting [11:56-13:12] More specifics in those area the physical environment and facility cleanliness along with cleaning and disinfection practices [13:13-14:55] Explaination of how joint Commission defines and evaluates immediate use compounding [14:56-16:09] The minimum required elements for immediate use compounding competency [16:10-17:12] Compounding competencies besides immediate use [17:13-17:54] Expectations for environmental services training [17:55- 20:14] Concerns around hazardous drugs [20:15- 21:14] Additional information   Links | Resources: Joint Commission: THE NEW STANDARD: Accreditation 360   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

On this episode, we define acute mania and describe its clinical presentations, underlying causes, and pathophysiology. We evaluate current guidelines and evidence-based treatment strategies for managing acute mania, including pharmacologic and nonpharmacologic interventions. We also compare and contrast the efficacy, safety profiles, and appropriate use of mood stabilizers, antipsychotics, and adjunctive therapies in the management of acute manic episodes. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

0:48: Intro 1:35: Common mistakes with inhalers 5:25: Tailoring inhaler education 9:10: Selecting the right inhaler for a patient 12:05: What an inhaler counseling session looks like 15:45: Tracking inhaler technique 18:06: Inhaler counseling in community pharmacies 21:24: Conclusion Jennifer Griffin, PharmD, MS, serves as a clinical pharmacist for Harps Food Stores, Inc., where she specializes in medical billing, point-of-care testing and treatment workflow, and marketing clinical services. She earned her Doctor of Pharmacy degree from Harding University College of Pharmacy in Searcy, Arkansas, and holds a Bachelor of Science in Healthcare Administration and a Master of Science in Health Promotion from the University of Central Arkansas. 

In this episode of the We Talk Health podcast, West Tennessee Healthcare Henry County Hospital CEO, Paula Bell joins us. Paula recently became the new CEO of Henry County Hospital, and as a native of Henry County, she shares her journey and how she plans to lead.Learn all about what's new at Henry County Hospital, hear all about Paula's background and more.Guest:Paula Bell, PharmD, BCPSCEO, Henry County HospitalHost:Kara MobleySocial Media Coordinator

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Forat Lutfi, MD Guest: Nilanjan Ghosh, MD, PhD For patients with relapsed/refractory large B-cell lymphoma, timely access to CAR T-cell therapy can be life-saving, but communication gaps between referring physicians and CAR T centers can lead to delays or missed opportunities. Fortunately, practical strategies like building strong referral networks, improving direct communication, and aligning on shared care responsibilities can streamline access and improve outcomes. Joining Dr. Charles Turck to share their insights on how we can bridge these communication gaps are Drs. Forat Lutfi and Nilanjan Ghosh. Dr. Lutfi is an Assistant Professor of Hematologic Malignancies and Cellular Therapeutics at University of Kansas Medical Center, and Dr. Ghosh is a Professor of Cancer Medicine at the Wake Forest University School of Medicine in Charlotte, North Carolina.

Today I am speaking with Dave Chase from Health Rosetta, and I'm asking Dave Chase three inferno-level burning questions—questions that, across the country, many self-insured employers are trying to find the answers to. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Now, an important underlying point that comes across loud and clear but remains unsaid, actually, in the conversation that follows is this: There are amazing brokers and EBCs (employee benefit consultants) and benefits advisors or TPAs (third-party administrators) who put their clients first and have the receipts (ie, they have data and they're willing to share it to prove this). And then there are those with the exact same titles, often enough, who are very much the opposite of this but super charming, I'm sure. I mean, it'd be a stretch to assume that the same roles don't apply to brokers or EBCs that apply for titles like hospital administrators where there's great ones and really not great ones; but everybody often gets lumped into the same category or even the term hospitals. Each of these terms is a broad stroke and contains multitudes. And do listen to the bonus clip from two weeks ago with Jonathan Baran for just more on this point. We dig into it for like 10 minutes or something. I also talk about this same concept in an upcoming episode with Mick Connors, MD. So, keep that underlying and unsaid theme in mind because a lot of these questions do boil down to, How do you figure out who's on the up-and-up and who's not? And if you need an example of the latter category, listen to the show with Ann Lewandowski (EP476) about the whistleblower lawsuit or the show with AJ Loiacono (EP379) about the myriad of brokers taking $7 or $14 per script written payable by the PBM (pharmacy benefit manager) and not reported on, as far as I know. This is very much still going on today, by the way, despite the CAA (Consolidated Appropriations Act) and the 5500 forms. Alright, so, first burning question, Question 1: After seeing J&J (Johnson & Johnson) and Wells Fargo sued for fiduciary breaches, what specific questions do I need to ask my benefits advisor to prove that my benefits advisor actually protects my interests? Okay, paraphrased, this question is employers trying to figure out what they can ask or how they can figure out if their benefits advisor or broker or employee benefit consultant is really as trustworthy as they'd like you to believe they are. There's been a whole bunch of shows that circle up on this. The thing is, though, the stakes are very, very high right now. So, yeah, I can see why this is turning into a burning question for anyone worried they might get sued personally unless they can figure out how to vet, for real in writing, who their broker, EBC, or advisor serves actually at the end of the day. Question 2 that I ask Dave Chase, and I'm not giving you the answers to these questions. You gotta listen to the show. But here's the second question I ask: How do I avoid personal liability when my TPA contract has hidden conflicts that could trigger an ERISA (Employee Retirement Income Security Act) lawsuit? Kind of a continuation of Question 1, but yeah, you can tell that self-insured employer teams are really digging in here and many, many are very aware of, first of all, the extent and depth of middle people doing things like, again, allegedly taking $20 million of employer clients' money and funding their executive bonus pool. So, yeah, definitely this is another doozy of a burning question. Also on these same topics, listen to the show with Justin Leader (EP433) and also the one with Cynthia Fisher (EP457) about spread pricing. Question 3 that I ask Dave Chase: My pharmacy costs keep climbing despite PBM guarantees. How do I tell if I am being systematically overcharged? Well, if your consultants are taking your rebates to fund their executive bonus pools, as I just mentioned there's a whole show about with Ann Lewandowski, or if they're taking $7 a script for every script that gets written for your members, which, yeah, that's afoot. I've seen the contracts and the cease and desists currently flying around our industry about that one. Or read that Osceola County lawsuit against their longtime brokers. Bottom line and end of this intro, informed employer teams are, for sure, wondering these questions. But even more than just wondering, what these questions signify to me, kind of at the macro level, they're realizing the danger of kind of sitting on that knowledge or just assuming that because everybody else is doing whatever, it's somehow safe—though status quo is getting kind of more and more dicey every single day. As some additional foreshadowing, this show finishes up with Dave Chase talking about the open-source resources that are available so that you too can create a high-performance health plan where members get higher-quality healthcare and, as Dave Chase says, the cost savings for free. There are links to many things that you can get from Health Rosetta and their sister company, Nautilus. Again, all the stuff is for free. Go to nautilushealth.org. That's their main Web site. Dave Chase, who has been on this podcast—I think this is his third time, although it has been a while—Dave Chase is co-founder and CEO of Health Rosetta. Also mentioned in this episode are Health Rosetta; Jonathan Baran; Mick Connors, MD; Ann Lewandowski; AJ Loiacono; Chris Deacon; VerSan Consulting; Justin Leader; Cynthia Fisher; Nautilus; Andreas Mang; Blackstone; Jon Camire; Claire Brockbank; Elizabeth Mitchell; Scott Haas; Paul Holmes; Chris Crawford; Luke Slindee, PharmD; Mark Cuban; Marilyn Bartlett, CPA, CGMA, CMA, CFM; Leah Binder; and Dawn Cornelis.   You can learn more at Health Rosetta and follow Dave on LinkedIn.   Dave Chase is on a mission to restore hope, health, and economic well-being to communities through healthcare transformation. As creator of the community-owned health plan (COHP) model, he is building a nationwide movement that turns health plans from drivers of wage stagnation into vessels for well-being and wealth creation. As founder of Health Rosetta, Dave has helped transform healthcare for thousands of employers covering more than five million Americans. What began with identifying just five successful health plans nationwide has grown into a movement with thousands of sustainable successes that deliver superior care at 20% to 50% lower costs. In 2024, his team launched Nautilus Health Institute, catalyzed with $4 million in Health Rosetta intellectual property and investment. Nautilus provides open-source standards, contracting templates, and technology infrastructure (including METL, an open-source healthcare data platform) that establish new market norms benefiting employers, clinicians, and communities. Dave's work in healthcare transformation has reached over 10 million people through best-selling books (The CEO's Guide to Restoring the American Dream, The Opioid Crisis Wake-up Call, Relocalizing Health), media, TED Talks, and TV/film appearances. He has received the World Health Care Congress's Lifetime Achievement Award for Health Benefits Innovation. Dave is dedicated to transforming healthcare through transparency, community ownership, and proven solutions that restore the American Dream.   06:36 What questions does a plan sponsor need to ask their consultant, EBC, or broker to ensure they are protecting the interest of the plan sponsor? 07:59 EP478 with Andreas Mang and Jon Camire. 08:49 EP453 with Claire Brockbank. 09:51 EP433 with Justin Leader. 09:53 EP436 with Elizabeth Mitchell. 11:03 How can plan sponsors avoid personal liability when their TPA has hidden conflicts of interest? 11:40 Tiara Yachts v. Blue Cross Blue Shield of Michigan lawsuit. 13:48 EP483 (Part 1) with Jonathan Baran. 14:18 EP457 with Cynthia Fisher. 16:18 The Marshall-Hickenlooper bill called the Price Tags Act. 16:50 Summer Short with Elizabeth Mitchell. 17:36 How do plan sponsors figure out if they are being overcharged for pharmacy benefits? 18:09 EP365 with Scott Haas. 20:18 EP397 with Paul Holmes. 20:22 EP465 with Chris Crawford. 20:37 EP429 with Luke Slindee, PharmD. 22:56 EP476 with Ann Lewandowski. 28:38 Where to find open-source resources to help guide plan sponsors with making better health plan decisions. 29:47 How the open-source trend is growing for health transparency. 30:48 What to look forward to at RosettaFest.   You can learn more at Health Rosetta and follow Dave on LinkedIn.   @chasedave discusses questions #plansponsors need to ask on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander, Dr Tom X Lee (Take Two: EP445), Dr Tom X Lee (Bonus Episode), Dr Benjamin Schwartz, Dr John Lee (Take Two: EP438), Kimberly Carleson, Ann Lewandowski (Summer Shorts), Andreas Mang and Jon Camire (EP479)

In this special episode, Tim Ulbrich introduces the winners of the YFP Gives scholarship. Deja Preusser, Zipporah Williams, Michaela Martin-Worley, Julia Miller, and Mildred Asamoah share their inspiring stories, showcasing the drive, resilience, and vision of the next generation of pharmacy leaders. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD introduces the five recipients of the 2025 YFP Gives Scholarship. These inspiring stories reflect the passion, perseverance, and leadership of the next generation of pharmacy professionals. The 2025 YFP Gives scholarship winners are Deja Preusser, Zipporah Williams, Michaela Martin-Worley, Julia Miller, and Mildred Asamoah. Now in its second year, the YFP Gives Scholarship provides each winner with a $1,000 scholarship, 1-year access to YFP+, a copy of Seven Figure Pharmacist, and a 1:1 Ask Me Anything session with Tim Ulbrich or Tim Baker.  Mentioned on the Show YFP YouTube Channel YFP Gives Your Financial Pharmacist

In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics' latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030. Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk's semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.The Evolution of GLP-1swww.primetherapeutics.comAll Pharmacy Friends episodesMetabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver healthThe views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginHow do you grow from one pharmacy to 32...and still sleep at night?That's a question unicorn pharmacy owners can answer and this week we're joined by one!In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA and Austin Murray sit down with Bill Osborn, President at Osborn Drugs and pharmacy industry veteran, for an unscripted, insightful conversation that spans decades of wisdom, wit, and work ethic.From navigating PBM reform and workforce shortages to embracing AI and technology, we jump into the "Pharmacy Time Machine" to discuss:- The evolving role of AI and automation in pharmacy- How Bill built a 32-store network rooted in local ownership- Partnership structures, buy-sell agreements, and long-term sustainability- And more!More About Our Guest: Bill Osborn is President of Osborn Drugs, Inc. and started working in the pharmacy in different capacities since the age of 13. A Miami OK native, Bill graduated from Miami High School (1978) and received his Associates degree (1980) from NEO A&M College. He obtained his Bachelor (1984) and Doctorate of Pharmacy (2003) from the University of Oklahoma.He currently serves as co-chair of Unify Rx and is on the board of AlignRx. Bill also serves on the board of directors of Surescripts, LLC, the Premier Value Alliance, and First National Bank of Miami. Bill served a 10-year term on the Oklahoma State Board of Pharmacy and is a current member of the Oklahoma Pharmacists Association and the American College of Apothecaries. Bill is a graduate of University of Oklahoma College of Pharmacy.Connect with Bill Osborn and Osborn Drugs:  Bill Osborn LinkedInProRx WebsiteOsborn Drugs WebsiteOsborn Drugs FacebookStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - PBM Reform Act and Medicare Drug Pricing Changes

Samantha Picking, PharmD, joined Over the Counter to discuss her role as Walgreens' senior director of immunizations during National Immunization Awareness Month.

We chat about neuromuscular blockade, monitoring, and reversal in the ICU, including why sugammadex isn't more widely used, with Sara J Hyland, PharmD, BCCCP, FCCP, researcher and clinical pharmacist in perioperative and emergency medicine. Learn more at the Intensive Care Academy! Takeaway lessons References

In this episode: Randy Lipps is Chairman, President, Chief Executive Officer, and Founder of Omnicell, a leader in transforming the pharmacy care delivery model. Under his leadership, Omnicell has grown from a single product offering to delivering the most comprehensive portfolio of medication management solutions across the continuum of care.Mr. Lipps founded Omnicell in 1992 after observing how inefficiently medical supplies were managed when his daughter was hospitalized at birth. Inspired by his work in airline industry operations and logistics, he sought to enable better management of supplies and medications to help improve patient care.Omnicell became a publicly traded company in August 2001, and today healthcare systems worldwide leverage the company's automation and advanced services offerings to maximize clinical and operational outcomes.In 2014 Mr. Lipps was elected to the Bellwether League Hall of Fame, an industry organization that honors healthcare supply chain innovators, pioneers, and visionaries.Mr. Lipps has made giving back to the community a priority at Omnicell. Omnicell Cares, the company's formalized charitable efforts program, translates this into action, making a positive difference by fostering opportunities for volunteerism, charitable giving, and raising awareness for critical topics and issues. Mr. Lipps and his wife, Kathy, have focused their own philanthropy on poverty, nursing and public education, pharmacy research, youth groups, and local community efforts. Mr. Lipps serves as a member of the Board of Trustees of the American Nurses Foundation.Prior to founding Omnicell, Mr. Lipps was Assistant Vice President of Sales and Operations for a division of American Airlines. He holds Bachelor degrees in both Economics and Business Administration from Southern Methodist University. Topics to discuss –Introduction to Randy and Omnicell and his journey leading the digital transformation of medication management Staffing shortages and employee retention are top problems facing employers today, especially hospitals and health systems. In the pharmacy, labor shortages have far-reaching impacts including reduced quality of patient care, increased workloads for staff, slow delivery of medications, growing operational costs and process inefficiencies that lead to medication errors. Automation for pharmacies could be the key to addressing these issues and optimizing hospital staff's efficiency to reduce labor gaps.How the Innovation Lab allows customers to get a firsthand look at how automation technologies can make their healthcare operations more efficient and enable nurses and pharmacists to spend more time caring for patients. The autonomous pharmacy vision. How pharmacy automation reduces medication errors through accurate dispensing, streamlines inventory management and real-time tracking, ensures controlled substance security and regulatory compliance, and gives nurses more time to focus on higher-value tasks that directly impact patient care.Guest - Randall Lipps is Chairman, President, Chief Executive Officer, and Founder of OmnicellSocial Media:LinkedIn: https://www.linkedin.com/in/randall-lipps-a76412195/Website: https://www.omnicell.comYouTube: https://www.youtube.com/@Omnicell1Host - Hillary Blackburn, PharmD, MBAhttps://www.linkedin.com/in/hillary-blackburn-67a92421/  ★ Support this podcast on Patreon ★

In this episode of The Positive Pause®, host Claire Gill speaks with Dr. Adrienne Bitar, PhD and Dr. Jennifer Han, PharmD, BCACP, co-founders of Seen Nutrition about their personal experiences with bone health issues, including pre-menopausal osteoporosis, the important role of calcium in bone health & bone density, how to protect bone health at midlife, and the creation of their brand & its new calcium chew. Drawing from their personal and family experiences with osteoporosis, they created a food-first calcium chew, free of added sugars, synthetics, preservatives, and fillers, to help women protect their bones across all stages of life.Adrienne Bitar, PhD is a food studies researcher and lecturer in the Program in American Studies at Cornell University. She is the author of Diet and the Disease of Civilization (published by Rutgers University Press in 2018), a cultural history of diets in the US and analyzes how the obesity epidemic and diet book narratives reflect and shape broad cultural, religious, historical, and moral meaning. An expert in gender studies, food research, and the history of nutrition, Bitar has been widely consulted by journalists in the academic and popular press. Jennifer Han, PharmD is a Board-certified ambulatory care pharmacist (BCACP) practitioner at Syracuse Veterans Affairs Health System in New York, where she directs the chronic pain and whole health program. She has treated patients with full scope of practice to prescribe medications for chronic conditions such as diabetes, obesity, hypertension, dyslipidemia, pain and heart disease. Previously at Pomona Valley Hospital in Los Angeles, CA, Dr. Han created the first interdisciplinary clinical pharmacy practice at the Women and Family Medicine Clinic, as well as serving as clinical faculty of the Family Medicine Residency and residency coordinator for the Pharmacy Residency Program.Key Points CoveredPersonal Journeys & MotivationUnderstanding Bone Health Across the LifespanCalcium's Role in Bone HealthThe Problem with Traditional SupplementsPrevention & Early ActionPractical Advice for ListenersResources Available: Purchase your first order of the Seen Calcium Chew Complete - 1 Month Supply for only $35Bone Health and Osteoporosis Foundation (BHOF)International Osteoporosis Foundation (IOF)IOF Calcium CalculatorDr. Han and Dr. Bitar emphasize prevention, education, and smarter supplementation.  Start now, start small, and prioritize your bones for lifelong strength and mobility.Connect with Dr. Bitar and Dr. Han: Website LinkedIn: https://www.linkedin.com/company/seennutrition  https://www.linkedin.com/in/adriennerosebitar https://www.linkedin.com/in/jennifer-han-pharmd-bcacp  FacebookInstagram

In this episode, our guest is Srulik Dvorsky, who is the co-founder and CEO of TailorMed. Drawing on his experiences caring for family members with cancer—and his background as a technological leader in the medical device space—he started TailorMed with a mission to remove barriers to care. Now the market's category leader, TailorMed offers the nation's largest affordability network spanning more than800 hospitals, 1,300 clinics, and 1,400 pharmacies, as well as premier life science companies. Under Srulik's leadership, TailorMed has received broad recognition for its impact and innovation, including Deloitte's Technology Fast 500 list and the New York Digital Health 100 list for three consecutive years. He holds a global MBA from the Arison School of Business at Reichman University and a BSc in electrical engineering from Tel Aviv University.Topics to discuss –1. Background on TailorMed, its mission, and its role for bringing down the cost of care for patientsFounding of TailorMed: After caring for several family members with cancer, Srulikwanted to leverage his expertise in technology to help solve a critical challenge in healthcare. He co-founded TailorMed in 2018 with a mission to help patients overcome barriers to care.2. Problem Overview: Affordability in Healthcare / Specialty Care:Rising medication costs lead many patients, particularly those who require specialty care, to delay or forgo therapy. About 1 in 5 U.S. adults says they have not filled a prescription, while 1 in 10 has cut pills in half or skipped doses in the last year,due to cost. This leads to higher rates of prescription abandonment and lossof revenue for pharmacies–and poor adherence and worseoutcomes for patients.3. How TailorMed Partners with Pharmacies:There is an abundance of financial assistance to help patients afford their medications, amounting to over $50 billion in total. These resources are underutilized because pharmacies and providers often lack a proactive approach to identify patients inneed and efficiently match them with assistance programs. TailorMed enables pharmacies and providers to flag financially at-risk patients and streamline program matching and enrollment. TailorMed began with provider partners and expanded to include top specialty pharmacies, infusion centers, and life science companies—building the nation's largest affordability network.4. Key Considerations for Pharmacy Teams Tackling MedicationAffordability:Streamline financial assistance workflows to proactively address cost barriers at scale.Embed affordability solutions into day-to-day operations to reduce administrative burden.Use data and automation to boost efficiency and support better patient outcomes.Prioritize change management and IT collaboration to ensure smooth adoption and long-term success of tech-driven solutions. Track both clinical and financial impact to refine your approachand promote best practices.Guest - Srulik Dvorsky, MBATailorMed's https://tailormed.co/ Srulik Dvorsky's LinkedIn: https://www.linkedin.com/in/srulik/ TailorMed's LinkedIn: https://www.linkedin.com/company/tailormed---medical-journey-innovations/ Host - Hillary Blackburn, PharmD, MBAwww.hillaryblackburn.comhttps://www.linkedin.com/in/hillary-blackburn-67a92421/  ★ Support this podcast on Patreon ★

Jasmine Gonzalvo, PharmD, MPH, CDCES, FADCES, joins this episode to discuss the importance of curiosity, effective communication and cultural sensitivity in diabetes care. She shares her personal approach to exploring barriers to insulin in clients and highlights how motivational interviewing can be a powerful tool in navigating treatment conversations—especially when addressing common misconceptions about insulin. The conversation emphasizes the importance of open-ended questions, recognizing personal biases, and creating safe spaces for honest dialogue. By nurturing relationships and meeting patients where they are, diabetes care and education specialists can better support lasting behavior change and improve health outcomes.This episode is sponsored by Lilly. ResourcesA link to the insulin myths tip sheet mentioned in this episode is coming soon. ReferencesNahid Dehghan-Nayeri, Fatemeh Ghaffari, Tahereh Sadeghi, Naser Mozaffari; Effects of Motivational Interviewing on Adherence to Treatment Regimens Among Patients With Type 1 Diabetes: A Systematic Review. Diabetes Spectr 1 May 2019; 32 (2): 112–117.Guy E H M Rutten, Heidi Van Vugt, Eelco de Koning - Person-centered diabetes care and patient activation in people with type 2 diabetes: BMJ Open Diabetes Research & Care 2020;8:e001926.Entwistle VA, Carter SM, Cribb A, McCaffery K. Supporting patient autonomy: the importance of clinician-patient relationships. J Gen Intern Med. 2010 Jul;25(7):741-5. doi: 10.1007/s11606-010-1292-2. Epub 2010 Mar 6. PMID: 20213206; PMCID: PMC2881979. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

John Hertig, PharmD, MS, CPPS, FASHP, is Founder of Hertig Healthcare Advising and former faculty in the Pharmacy Practice Department in the Butler University College of Pharmacy and Health Sciences. He is also Past-President and a current Board of Directors member of the Alliance for Safe Online Pharmacies and is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee. In this episode, he discusses his career, the online pharmacy landscape, the challenges and risks associated with illegal online pharmacies, how athletes and others can help keep themselves safe when accessing medications online, and more.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTF865. CME/MOC/AAPA credit will be available until August 30, 2026.Building Confidence in RSV Vaccination: Addressing Vaccine Hesitancy and Inequities in At-Risk Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/TTF865. CME/MOC/AAPA credit will be available until August 30, 2026.Building Confidence in RSV Vaccination: Addressing Vaccine Hesitancy and Inequities in At-Risk Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

In this IVPN Critical Care x IVPN Voice collaboration, we dive into the concept of Fluid Stewardship: Fluids are Drugs.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Jacqueline Wong, MD, MSCR, FACOG For patients with endometriosis, treatment delays can profoundly impact both quality of life and clinical outcomes. Proactive strategies that address logistical barriers—such as prior authorizations—combined with education and multidisciplinary support are essential in improving care. Join Dr. Charles Turck and Dr. Jacqueline Wong as they explore practical approaches for managing this complex condition and navigating potential hurdles. Dr. Wong is a minimally invasive gynecologic surgeon and an Assistant Professor of Obstetrics and Gynecology in the School of Medicine at Oregon Health and Science University in Portland.

ASHP's senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include: Leveraging pharmacists' expertise to advance HIV treatmentPharmacist roles in HIV care and management The current ART landscapeRegimen simplificationConsideration of patient preferences, health factors, and comorbidities for ART optimizationART management for treatment-experienced patients, including those with multidrug-resistant HIVPresenters:Alexis E. Horace, PharmD, BCACPProfessor of Pharmacy PracticeUniversity of Louisiana at Monroe College of PharmacyNew Orleans CampusCrescentCare Ambulatory Care Clinical Pharmacist, HIV SpecialtyNew Orleans, LouisianaNimish Patel, PharmD, PhD, AAHIVPProfessor of Clinical PharmacyDivision of Clinical PharmacySkaggs School of Pharmacy & Pharmaceutical SciencesUniversity of California, San DiegoLa Jolla, CaliforniaLink to full program: https://bit.ly/41agtqQGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

*This podcast episode was originally a YouTube LIVE with Q&A which you can watch on my YouTube channel ⁠⁠here⁠⁠. This is a series of episodes I am doing on non-traditional careers running from July to December 2025. Sign up to my shared Google Calendar ⁠⁠here⁠⁠ so you never miss an episode*Tired of traditional pharmacy roles? Meet Dr. Steve Aluoch, the PharmD who might be behind some of your favourite drug commercials on TV. In this episode, Steve shares how he transformed his clinical background into a six-figure medical communications career, earning $80K-$180K+ while working remotely with global pharmaceutical companies. Discover what medical communications really is, the day-to-day life of a medical writer, exact salary ranges by experience level, and Steve's step-by-step path from dispensing medications to creating compelling content that reaches millions. If you're a pharmacist looking for creativity, better work-life balance, and higher earning potential, this non-traditional career path might be your perfect pivot.

On this exciting episode of the IPhO Podcast, we're shining a spotlight on the unique experiences of fellows working in one of the most critical phases of drug development: late-stage clinical development! Joining us are three fellows from the Merck Late Stage Clinical Development Fellowship Program: Vivian Tran, PharmD, Late Stage Clinical Development, General and Specialty Medicine; Lauren Dougherty, PharmD, Late Stage Clinical Development, Oncology; and Shakhzoda Rakhimova, PharmD, RPh, Late Stage Clinical Development, ID/Vaccines. In this conversation with their co-fellow and host, Alena Abraham, PharmD, they share their personal journeys into clinical development, what guided them toward their specific therapeutic areas, and how they've tackled common challenges, such as steep learning curves and navigating collaboration difficulties. They also highlight the key skills that have helped them thrive in their roles and offer valuable advice for students considering a similar path. Whether you're exploring fellowship options or have a strong interest in clinical development, this episode offers insider insight you won't want to miss!

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginTechnology, retaining talent, filling needs in your community. We cover it all and more in this sit down with Dr. Hashim Zaibak, PharmD, Founder and CEO of Hayat Pharmacy.In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with Hashim Zaibak, PharmD, to discuss:- The future of AI in pharmacy- Why communication is the most underrated hiring skill- The hidden impact of pharmacy deserts on urban communities- And more!More About Our Guest: Hashim Zaibak is the Founder and CEO of Hayat Pharmacy, an independent pharmacy with over 20 locations serving the Milwaukee area.  Dr. Zaibak started his career as a pharmacist in 1999 after graduating from the University of Illinois‐Chicago. With over fifteen years of experience, he has seen the industry from multiple vantage points. Aside from Hashim's experience, he is well known as a helpful educated medical counselor. He dedicates time to giving health education presentations and teaching patients proper medication administration.  Dr. Zaibak has over six years of experience as a Clinical Instructor to help train pharmacy students from six pharmacy schools in the Wisconsin and Illinois area (Concordia University, Rosalind Franklin University, University of Wisconsin, University of Illinois, Midwestern University, and MCW School of Pharmacy). As recognition of Hashim's excellent service to the community, he was named the 2014 Pharmacist of the Year by Pharmacy Development Services and Health Mart's 2014 Pharmacy of the Year. Connect with Hashim Zaibak and Hayat Rx below:  Hashim Zaibak LinkedInHayat Pharmacy WebsiteHayat Pharmacy FacebookHayat Pharmacy InstagramHayat Pharmacy LinkedIn Hayat Pharmacy TwitterStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast - Momentum on the Hill: Protecting Independent Pharmacies Through AdvocacyPodcast - Building a Super Culture in Your Pharmacy

Ashley Kay Pendrick, PharmD, joined Over the Counter to discuss her work with Prosper Rx Consulting and how pharmacists have more opportunities than ever to step out of their comfort zones within the profession.

Introducing Melissa Smith, PharmD, CPH, CPGx, Founder of Florida PGX Consulting, and the new host of the Precision Health and PGX Podcast! Dr. Melissa is joined by her guests Dr. Jamie Wilkey & Dr. Jackie Boyle to discuss their introduction to precision medicine in PGX, as well as their friendship that encouraged it!

Guests:

Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.Topics covered include:The importance of good blood culture practices and finding the balance between overuse and underuseBlood culture improvement programsThe utility of rapid diagnostic testsResistance markers for earlier targeted therapyPresenters:Emily Heil, PharmD, MS, BCIDP, AAHIVPProfessorDepartment of Practice, Sciences, and Health Outcomes ResearchUniversity of Maryland School of PharmacyBaltimore, MarylandLink to full program: https://bit.ly/45Ajz92Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Uncontrolled hypertension continues to drive cardiovascular risk and remains a major gap in chronic disease management. This episode discusses what pharmacists need to know to support treatment adherence, identify therapeutic gaps, and address barriers to blood pressure control. Listen to strengthen your role in helping patients achieve meaningful, sustained outcomes. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTRyan Jacobsen, PharmD, BCPSClinical Pharmacy SpecialistU of Iowa HealthCareJoshua Davis Kinsey and Ryan Jacobsen have no relevant financial relationships to disclose. Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common causes and consequences of uncontrolled hypertension in various patient populations.2. Describe the pharmacist's role in recognizing gaps in therapy, addressing adherence, and supporting blood pressure control.0.05 CEU/0.5 HrUAN: 0107-0000-25-271-H01-PInitial release date: 8/11/2025Expiration date: 8/11/2026Additional CPE details can be found here.

Uncontrolled hypertension continues to drive cardiovascular risk and remains a major gap in chronic disease management. This episode discusses what pharmacists need to know to support treatment adherence, identify therapeutic gaps, and address barriers to blood pressure control. Listen to strengthen your role in helping patients achieve meaningful, sustained outcomes. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTRyan Jacobsen, PharmD, BCPSClinical Pharmacy SpecialistU of Iowa HealthCareJoshua Davis Kinsey and Ryan Jacobsen have no relevant financial relationships to disclose. Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify common causes and consequences of uncontrolled hypertension in various patient populations.2. Describe the pharmacist's role in recognizing gaps in therapy, addressing adherence, and supporting blood pressure control.0.05 CEU/0.5 HrUAN: 0107-0000-25-271-H01-PInitial release date: 8/11/2025Expiration date: 8/11/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

“We're really using these in many, many types of malignancies. But you can see this class of drug, these monoclonal antibodies, the small molecule inhibitors, being used in colorectal cancer, ovarian cancer, renal cell carcinoma, brain cancers, hepatocellular, non-small cell lung cancer, gynecologic malignancies, so lots of different types of cancers where we're seeing these drugs used,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the vascular endothelial growth factor (VEGF) inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 8, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of VEGF inhibitors in the treatment of cancer. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 303: Cancer Symptom Management Basics: Ocular Toxicities Episode 244: Cancer Symptom Management Basics: Cardiovascular Complications Episode 196: Oncologic Emergencies 101: Bleeding and Thrombosis Episode 161: Administer Bevacizumab Infusions With Confidence ONS Voice articles: Manage Afatinib's Adverse Events to Keep Patients on Treatment Oncology Drug Reference Sheet: Cabozantinib Oncology Drug Reference Sheet: Fruquintinib Patient Education Needs With Pazopanib Therapy for Soft Tissue Sarcoma ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: Safe Handling Basics Clinical Journal of Oncology Nursing article: Safety and Adverse Event Management of VEGFR-TKIs in Patients With Metastatic Renal Cell Carcinoma Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit IV Cancer Treatment Education Sheets Oral Chemotherapy Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Cancer cells are known to secrete factors that cause the formation of new blood vessels, and tumors need blood vessels to supply themselves with nutrients so that they can grow and metastasize. A lot of tumors overexpress these factors, so they had more of this ability to create new blood vessels. You may hear that term somewhere neo vascularization. … And also these factors can increase the permeability of blood vessels, so making them kind of leaky blood vessels. … So the thought behind it is being able to block the ability for this new blood vessel formation and to decrease that leakiness or permeability of those blood vessels.” TS 2:07 “These are drugs that are tyrosine kinase inhibitors. These are oral, small molecule drugs that are acting intracellular, so they are working within the cell to bind and prevent that downstream signaling of producing more blood vessels. So we have a number of small molecule drugs that fall into this class. Many of them target multiple types of receptors, VEGF being included, but also a lot of these drugs have other targets.” TS 7:58 “I would really say, number one, something that we very commonly see with this drug class is hypertension. Giving you an example of bevacizumab—If we look at any grade hypertension, this can be up to 67% of patients, so very common toxicity really spanning all of these agents. So something that we need to be monitoring closely for.” TS 13:24 “With that impaired wound healing, keeping that in mind, as we are planning for this agent, for patients and even sometimes with the minor surgical procedures, maybe a need for a short hold, and even for something like a catheter placement. I know and some of the providers I work with have a preference for holding for a short period of time around that as well.” TS 20:15 “I think one big area, and we've seen some of this just recently, and particularly in the hepatocellular setting, we're seeing combinations of using the VEGF inhibitor class with immunotherapy. And so I think we're going to continue to see that evolve. Even hearing about some bispecific antibodies that are in development, where they are targeting VEGF as well as PD-L1, so getting the immunotherapy and VEGF effects.” TS 24:44

It was truly an honor and a great pleasure to talk to a well-respected colleague and friend about his experience as both a pharmacist and an expert in the natural products field. He is a true embodiment of the Myth, Man and Legend. Tune in to learn more about filling in the gaps in the current healthcare climate by utilizing evidence-backed nutraceuticals. Dr. Jeffery A. Johnson, ND, PharmD, RPh, MBA is a dedicated healthcare professional and 30-year combat veteran of the U.S. Armed Forces (USAF). A graduate of Purdue University (BS-Pharm, 1978), he later earned his Doctor of Naturopathy (2000), Doctor of Pharmacy from the University of Kansas (2003), and an MBA. Throughout his career, Dr. Johnson has spent over three decades educating and consulting with healthcare professionals and clients on the integration of nutraceuticals into personal healthcare practices—highlighting both their benefits and potential challenges. Since retiring from active military service in 2017, he has continued his mission of promoting informed, holistic healthcare practices. He currently works part-time as a self-employed Consultant Pharmacist, offering expert guidance on nutraceuticals and overall wellness strategies. Connect with Jeffery via: Email: ntrxpathconsultants@outlook.com Linked In: Dr Jeffery A (Doc Pappy J) Johnson Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Anticipating and managing CDK4/6 inhibitor toxicities in HR+ HER2- breast cancer is essential to improving patient quality of life and optimizing clinical outcomes. In this episode, CANCER BUZZ speaks with Diana Van Ostran, PharmD, BCOP, clinical pharmacy specialist – breast clinic at Miami Cancer Institute, Baptist Health South Florida, about strategies to monitor and manage treatment-related adverse events in patients with early-stage and metastatic breast cancer receiving CDK4/6 inhibitors. She discusses the importance of individualized care and robust patient education around lifestyle and dietary techniques to improve tolerance of this treatment.   Diana Van Ostran, PharmD, BCOP  Clinical Pharmacy Specialist – Breast Clinic Miami Cancer Institute Baptist Health South Florida  Miami, FL   “Clinical pharmacists play a vital role in managing the patient's treatment. Because, as we know, if you're having excessive side effects, patients are going to be less likely to take their medications.”   Resources: ACCC Adverse Event Management for CDK Inhibitors in HR+ Breast Cancer ACCC CDK Inhibitors Management Miami Cancer Institute ACCC Spotlight on Miami Cancer Institute: The Role of a Breast Cancer Clinical Pharmacy Specialist for CDK4/6 Inhibitor Management

On this episode, we provide an overview of insulin. We discuss the various insulin products available, basal vs prandial insulin, and dosing strategies. We also review clinical concepts such as overbasalization.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

We're diving into the first-ever treatment that can delay the onset of type 1 diabetes—Tzield—and hearing from two powerful voices helping spread the word about screening. First, Pelaton star Robin Arzon shares her personal journey - managing diabetes through marathons, pregnancy, and parenting—and why she believes time and information are two of the most valuable tools in diabetes care. We're also going to learn more about Tzield itself from Dalila Masic, PharmD. We're talking about how this works now, who its for, and the future of prevention. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about Tzield here Robin Arzon and Barbie video here  Join us at an upcoming Moms' Night Out event! Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.